SYNGENE

Syngene International Share Price

₹845.00 -5.8 (-0.68%)

21 Nov, 2024 14:28

SIP TrendupStart SIP in SYNGENE

Start SIP

Performance

  • Low
  • ₹840
  • High
  • ₹855
  • 52 Week Low
  • ₹608
  • 52 Week High
  • ₹945
  • Open Price₹848
  • Previous Close₹851
  • Volume115,108

Investment Returns

  • Over 1 Month -3.72%
  • Over 3 Month + 1.87%
  • Over 6 Month + 22.31%
  • Over 1 Year + 16.34%
SIP Lightning

Smart Investing Starts Here Start SIP with Syngene International for Steady Growth!

Invest Now

Syngene International Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 70.6
  • PEG Ratio
  • -21.4
  • Market Cap Cr
  • 34,014
  • P/B Ratio
  • 8
  • Average True Range
  • 24.14
  • EPS
  • 11.45
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -0.34
  • RSI
  • 42.63
  • MFI
  • 63.67

Syngene International Financials

Syngene International Technicals

EMA & SMA

Current Price
₹845.00
-5.8 (-0.68%)
pointer
  • stock-down_img
  • Bullish Moving Average 5
  • stock-up_img
  • Bearish Moving Average 11
  • 20 Day
  • ₹871.30
  • 50 Day
  • ₹867.25
  • 100 Day
  • ₹839.91
  • 200 Day
  • ₹798.78

Resistance and Support

852.7 Pivot Speed
  • R3 877.40
  • R2 869.80
  • R1 860.30
  • S1 843.20
  • S2 835.60
  • S3 826.10

What's your outlook on Syngene International?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Syngene International Ltd. is a leading contract research, development, and manufacturing organization (CRDMO) in India, providing integrated services to global pharmaceutical, biotechnology, and agrochemical companies. It focuses on drug discovery, development, and commercial manufacturing.

Syngene Inter has an operating revenue of Rs. 3,451.10 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 18% is great, ROE of 11% is good. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 10% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 9% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 43 which is a POOR score indicating inconsistency in earnings, a RS Rating of 59 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 32 indicates it belongs to a strong industry group of Medical-Research Eqp/Svc and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Syngene International Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-23 Quarterly Results
2024-07-24 Quarterly Results
2024-04-24 Audited Results & Final Dividend
2024-01-25 Quarterly Results
2023-10-17 Quarterly Results
Date Purpose Remarks
2024-06-28 FINAL Rs.1.25 per share(12.5%)Final Dividend
2023-06-30 FINAL Rs.0.50 per share(5%)Final Dividend
2022-07-01 FINAL Rs.0.50 per share(5%)Final Dividend
2022-07-01 SPECIAL Rs.0.50 per share(5%)Special Dividend

Syngene International F&O

Syngene International Shareholding Pattern

54.72%
13.58%
2.91%
20.72%
0%
5.46%
2.61%

About Syngene International

  • NSE Symbol
  • SYNGENE
  • BSE Symbol
  • 539268
  • Managing Director & CEO
  • Mr. Jonathan Hunt
  • ISIN
  • INE398R01022

Similar Stocks to Syngene International

Syngene International FAQs

Syngene International share price is ₹845 As on 21 November, 2024 | 14:14

The Market Cap of Syngene International is ₹34014.4 Cr As on 21 November, 2024 | 14:14

The P/E ratio of Syngene International is 70.6 As on 21 November, 2024 | 14:14

The PB ratio of Syngene International is 8 As on 21 November, 2024 | 14:14

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23